EU: Coca-Cola Enterprises confirms three-way bottler merger
Coca-Cola Enterprises an independent bottler of Coke products in Europe, agreed to a three-way merger with two other bottlers in
Coca-Cola Enterprises an independent bottler of Coke products in Europe, agreed to a three-way merger with two other bottlers in
The Competition and Consumer Protection Commission has taken action against Vodafone Ireland after it found that the telecoms firm was
The Taiwan Fair Trade Commission has closed two investigations into Google Inc. and found no violations, a positive step for
US regulators officially closed the door on T-Mobile’s request for more airwaves in the upcoming auction of TV broadcast spectrum
An upcoming conference on intellectual property has triggered a controversy, as a section of the civil society has urged the
Springleaf Holdings Inc said its deal to buy subprime lender OneMain Financial Holdings from Citigroup Inc could be delayed beyond
The competition regulator has accused Pfizer and Flynn Pharma of breaching UK and European law by ramping up the cost
Hospitals urged antitrust regulators this week to consider whether health insurer Anthem Inc.’s planned acquisition of rival Cigna Corp. would
Posted by Social Science Research Network Nonprice Competition in ‘Substitute’ Drugs: The FTC’s Blind Spot Gregory Dolin (University of Baltimore)
Axel Springer SE would have “loved” to buy the Financial Times, but the $1.3 billion Nikkei Inc. paid for the
© Competition Policy International 2024